Japanese Simple Chinese Traditional Chinese Korean 

Conference Menu

Current Event

Overview
Short Course
Day 1
Day 2
Day 3
PDF Download
Posters
Hotel & Travel 
Sponsor & Exhibits
Press Pass 
Request Brochure 
Archives  

AGILENT NEW logo 

Life_Technologies 

Reaction Biology 

Sigma_NEW 

GEN 

nature 

Science AAAS 

PharmaVoice 

The Scientist 

Markets and Markets logo 

Pharmaphorum 

PharmCast 

Reports and Reports 


Next-Gen Kinase Inhibitors

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Final Weeks to Register! 

TOPIC HIGHLIGHTS 

ArrowDesigning, Screening and Assessing Selectivity 

ArrowIdentifying and Assaying Allosteric Kinase Inhibitors 

ArrowCovalent Inhibition 

ArrowKinases for CNS Indications – An Exciting Challenge 

ArrowInflammation& Autoimmune – Leading Programs 

ArrowKinases in Oncology – PI3, mTOR, cMet  & More 

ArrowNovel Kinase Targets in Hot Pursuit 

ArrowScreening & Monitoring DMPK and Tox 

ArrowAdvances in Computational Methods 

ArrowResistance – Future Challenges 


Click here for the final agenda 


Distinguished Faculty 

Mark Ashwell, ArQule Inc
James Blake, Array BioPharma, Inc.
Peter Brandt, Beactica AB
Stephen K. Burley, Eli Lilly & Company
Dirksen Bussiere, Novartis Vaccines & Diagnostics Inc.
Josette Carnahan, Amgen
Kenneth Comess, Abbott Laboratories
Jean Cui, Pfizer, Inc.
Greg Cuny, Brigham & Women’s Hospital
David C. Dalgarno, ARIAD Pharmaceuticals Inc.
David H. Drewry, GlaxoSmithKline
Isabelle Dussault, Amgen
Doriano M. Fabbro, Novartis Institutes for BioMedical Research
Jordan S. Fridman, Incyte Corp.
Daniel Goldberg, Karos Pharmaceuticals, Inc.
Andrew C. Good, Genzyme Corp
John D. Haley, OSI Pharmaceuticals
Stephanos Ioannidis, AstraZeneca
Ronald Knegtel, Vertex Pharmaceuticals (Europe) Ltd.
Ravi G. Kurumbail, Pfizer, Inc.
Chris Liang, Xcovery, LLC
Carol MacKintosh, University of Dundee
Henrik Mobitz, Novartis
Yibing Shan, D. E. Shaw Research
Juswinder Singh, Avila Therapeutics, Inc.
Rajinder Singh, Rigel Pharmaceuticals Inc.
Kent Stewart, Abbott
Eli Wallace, Array BioPharma
Neil Wishart, Abbott
Paul Yu, Massachusetts General Hospital
Donald Zack, Johns Hopkins University School of Medicine
 



Specialized Panels:

I. Next Generation Kinases –
Selectivity What Now?
 

II. Structure-Based Kinase
Inhibitor Design
 

Presented by hand-selected panelists who have contributed more than a decade
of research to the kinase field!
 

 


June 6th Half Day
Pre-Conference Short Course:

The Art and Science of Kinases -
What you Need to Know
 

Kent Stewart, Ph.D. Research Fellow, Abbott 


Co-Located with:11th Annual Structure-Based Drug Design Conference
June 8-10
 


 


By Series:
By Region: